ARTICLE
|
doi:10.20944/preprints202312.0525.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
SARS-CoV-2, COVID-19, Tixagevimab, Cilgavimab, Rituximab, immunosuppression
Online: 7 December 2023 (11:59:50 CET)
BRIEF REPORT
|
doi:10.20944/preprints202403.0928.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
systemic sclerosis; pulmonary hypertension; Phosphodiesterase-5 inhibitors; endothelin receptor antagonist
Online: 15 March 2024 (13:15:50 CET)